» Articles » PMID: 31102537

Glucose-6-Phosphate Regulates Hepatic Bile Acid Synthesis in Mice

Abstract

It is well established that, besides facilitating lipid absorption, bile acids act as signaling molecules that modulate glucose and lipid metabolism. Bile acid metabolism, in turn, is controlled by several nutrient-sensitive transcription factors. Altered intrahepatic glucose signaling in type 2 diabetes associates with perturbed bile acid synthesis. We aimed to characterize the regulatory role of the primary intracellular metabolite of glucose, glucose-6-phosphate (G6P), on bile acid metabolism. Hepatic gene expression patterns and bile acid composition were analyzed in mice that accumulate G6P in the liver, that is, liver-specific glucose-6-phosphatase knockout (L-G6pc ) mice, and mice treated with a pharmacological inhibitor of the G6P transporter. Hepatic G6P accumulation induces sterol 12α-hydroxylase (Cyp8b1) expression, which is mediated by the major glucose-sensitive transcription factor, carbohydrate response element-binding protein (ChREBP). Activation of the G6P-ChREBP-CYP8B1 axis increases the relative abundance of cholic-acid-derived bile acids and induces physiologically relevant shifts in bile composition. The G6P-ChREBP-dependent change in bile acid hydrophobicity associates with elevated plasma campesterol/cholesterol ratio and reduced fecal neutral sterol loss, compatible with enhanced intestinal cholesterol absorption. Conclusion: We report that G6P, the primary intracellular metabolite of glucose, controls hepatic bile acid synthesis. Our work identifies hepatic G6P-ChREBP-CYP8B1 signaling as a regulatory axis in control of bile acid and cholesterol metabolism.

Citing Articles

Bile acid metabolism in type 2 diabetes mellitus.

Cadena Sandoval M, Haeusler R Nat Rev Endocrinol. 2025; .

PMID: 39757322 DOI: 10.1038/s41574-024-01067-8.


Oral augments glycemic control in type 2 diabetes.

Attaye I, Witjes J, Koopen A, van der Vossen E, Zwirs D, Wortelboer K iScience. 2024; 27(8):110455.

PMID: 39139405 PMC: 11321313. DOI: 10.1016/j.isci.2024.110455.


Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia.

Rutten M, Lei Y, Hoogerland J, Bloks V, Yang H, Bos T Cancer Metab. 2023; 11(1):5.

PMID: 37085901 PMC: 10122297. DOI: 10.1186/s40170-023-00305-3.


The role of ChREBP in carbohydrate sensing and NAFLD development.

Regnier M, Carbinatti T, Parlati L, Benhamed F, Postic C Nat Rev Endocrinol. 2023; 19(6):336-349.

PMID: 37055547 DOI: 10.1038/s41574-023-00809-4.


The Role of Bile Acids in Cardiovascular Diseases: from Mechanisms to Clinical Implications.

Zhang S, Zhou J, Wu W, Zhu Y, Liu X Aging Dis. 2023; 14(2):261-282.

PMID: 37008052 PMC: 10017164. DOI: 10.14336/AD.2022.0817.


References
1.
Haeusler R, Pratt-Hyatt M, Welch C, Klaassen C, Accili D . Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metab. 2011; 15(1):65-74. PMC: 3253887. DOI: 10.1016/j.cmet.2011.11.010. View

2.
Huaman Samanez C, Caron S, Briand O, Dehondt H, Duplan I, Kuipers F . The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism. Arch Physiol Biochem. 2012; 118(3):102-11. DOI: 10.3109/13813455.2012.683442. View

3.
Bandsma R, Grefhorst A, van Dijk T, van der Sluijs F, Hammer A, Reijngoud D . Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice. Diabetologia. 2004; 47(11):2022-31. DOI: 10.1007/s00125-004-1571-8. View

4.
Hasegawa J, OSATOMI K, Wu R, Uyeda K . A novel factor binding to the glucose response elements of liver pyruvate kinase and fatty acid synthase genes. J Biol Chem. 1999; 274(2):1100-7. DOI: 10.1074/jbc.274.2.1100. View

5.
van Waarde W, Verkade H, Wolters H, Havinga R, Baller J, Bloks V . Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats. Gastroenterology. 2002; 122(7):1842-52. DOI: 10.1053/gast.2002.33582. View